MSC-Exos have been shown to modulate NLRP3 inflammasome activity and attenuate spinal neuroinflammation in interstitial cystitis by inhibiting NLRP3 inflammasome activation and downregulating TLR4/NF-κB signaling pathway activity (236). This evidence concerns the gene NLRP3 and interstitial cystitis.